1. ScholarBank@NUS

Eu Leong Yong

rp08015

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Eu Leong Yong
Variants
Yong, E.-L.
YONG, EU LEONG
Yong, E.L.
Eu, L.Y.
 
Main Affiliation
 
Faculty
 
Email
obgyel@nus.edu.sg
 

Publications

Results 41-60 of 142 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
412007DiscussionRussell, R.M.; Yetley, E.A.; Halliwell, B. ; Przyrembel, H.; Eu, L.Y. ; Taylor, C.L.; Rayman, M.; Katan, M.B.; Ernst, E.; Coates, P.M.; Scott, J.M.; Aggett, P.J.; Azzi, A.; Boobis, A.R.
422007DiscussionTaylor, C.L.; Aggett, P.J.; Yong, E.L. ; Przyrembel, H.; Manach, C.; Alexander, J.; Katan, M.B.; Azzi, A.; Shekelle, P.; Boobis, A.R.; Wharton, B.; Halliwell, B. ; Yetley, E.A.; Ernst, E.
432006Dynamics of progestogenic activity in serum following administration of Ligusticum chuanxiongLim, L.S.; Shen, P. ; Gong, Y.H. ; Yong, E.L. ; Lee, L.S.
442016Erratum: Respiratory consequences of N95-type Mask usage in pregnant healthcare workers-a controlled clinical study [Antimicrobial Resistance and Infection Control, 5, 26, (216)] DOI 1.1186/s13756-16-125-4Tong P.S.Y. ; Kale A.S. ; Ng K. ; Loke A.P.; Choolani M.A. ; Lim C.L.; Chan Y.H. ; Chong Y.S. ; Tambyah P.A. ; Yong E.-L. 
4519-Jul-2019Ethnic differences in bone mineral density among midlife women in a multi-ethnic Southeast Asian cohortThu, Win Pa Pa ; Logan, Susan JS ; Cauley, Jane A; Kramer, Michael S ; Yong, Eu Leong 
461-Nov-2016Ethnic differences: Is there an Asian phenotype for polycystic ovarian syndrome?Huang, Zhongwei; Yong, Eu-Leong 
4715-Jun-2021Excess mortality after hip fracture: fracture or pre-fall comorbidity?Liow, MHL; Ganesan, G; Chen, JDY; Koh, JSB; Howe, TS; Yong, E.L. ; Kramer, MS; Tan, KB
481-Oct-2020Factors associated with re-initiation of antidepressant treatment following discontinuation during pregnancy: a register-based cohort studyWikman, A; Skalkidou, A; Wikström, AK; Lampa, E; Kramer, MS ; Yong, EL ; Skoglund, C; Epperson, N; Sundstrom-Poromaa, I 
492003Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functionsLoy, C.J. ; Sim, K.S. ; Yong, E.L. 
502007Final discussionAggett, P.J.; Alexander, J.; Azzi, A.; Boobis, A.R.; Coates, P.M.; Yetley, E.A.; Manach, C.; Przyrembel, H.; Rayman, M.; Scott, J.M.; Stocker, R.; Taylor, C.L.; Yong, E.L. 
512007Final discussionAggett, P.J.; Alexander, J.; Azzi, A.; Boobis, A.R.; Coates, P.M.; Manach, C.; Przyrembel, H.; Rayman, M.; Scott, J.M.; Stocker, R.; Taylor, C.L.; Yetley, E.A.; Yong, E.L. 
5219-Nov-2018FRAX (R) based intervention thresholds for management of osteoporosis in Singaporean womenChandran, M; McCloskey, EV; Thu, WPP ; Logan, S ; Hao, Y; Tay, D; Ang, WC; Aung, TKK; Choo, KS; Ali, A; Yan, SX; Huang, XF; Liu, XM; Yong, EL ; Lekamwasam, S
532000Genetics of male infertility: Role of androgen receptor mutations and Y-microdeletionsYong, E.L. ; Lim, J. ; Wang, Q. ; Mifsud, A.; Ong, Y.C.; Sim, C.K.S.
542000Genetics of male infertility: Role of androgen receptor mutations and Y-microdeletionsYong, E.L. ; Lim, J.; Wang, Q.; Mifsud, A.; Ong, Y.C.; Sim, C.K.S. 
552005Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-γ ligand, pioglitazoneLoy, C.J.; Evelyn, S.; Lim, F.K.; Liu, M.H.; Yong, E.L. 
562020Health Information Needs of 1000 Midlife Singaporean WomenJeslyn Wong; Win Pa Pa Thu ; Chun Wei Lim, Luna Wang; Eu Leong Yong ; Susan Logan 
571-Sep-2021Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndromePersson, S; Elenis, E; Turkmen, S; Kramer, MS; Yong, E.L. ; Poromaa, IS
581-Apr-2019Hip fractures in Singapore: ethnic differences and temporal trends in the new millenniumYong, EL ; Ganesan, G; Kramer, MS ; Logan, S ; Lau, TC ; Cauley, JA; Tan, KB
592000Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2)Lim, J. ; Ghadessy, F.J. ; Abdullah, A.A.R.; Pinsky, L.; Trifiro, M.; Yong, E.L. 
602000Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2)Lim, J. ; Ghadessy, F.J. ; Abdullah, A.A.R.; Pinsky, L.; Trifiro, M.; Yong, E.L.